BZPEERPapers, people, evidence and research paths
Menu

Discover

SearchFind papers, people, topics, institutions and opportunities from one place.GraphSee how papers, authors, topics and evidence connect.

Research tools

HomeContinue from the papers, people and topics that matter now.CollectionsTurn saved papers into reading lists, evidence maps and shareable context.ResearchReconstruct the path that led you from search to paper to question.CollaborationMove from a paper, topic or expert request into a focused thread.PublishCreate full-text research articles with metadata, formulas and versions.

Network

ExpertsFind specialists whose work and reviews explain why they can help.CommunitiesJoin research groups organized around papers, topics and shared evidence.

Opportunities

ListingsBrowse roles, calls and collaborations connected to real research context.

Account

Log inReturn to your saved papers, graph views and active threads.Create accountStart saving papers, building a research trail and joining teams.
Log inCreate account

Source author record

Yoichi Watanabe

Yoichi Watanabe appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record
Tissues and Organsphysics.med-pheess.IVmath.OCQuantitative Methods

Catalog footprint

What is connected

4works
5topics
4close collaborators

Actions

Connect this record

Log in to claim
Open graphBrowse works

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2022arXiv

Classification of anatomic structures in head and neck by CT-based radiomics

Background and Purpose: Radiomics features are used to identify disease types and predict therapy outcomes. However, how the radiomics features are different among different anatomical structures has never been investigated. Hence, we analyzed the radiomics features of 22 anatomical structures in the head and neck area in CT images. Furthermore, we studied whether CT radiomics can classify anatomical structures of the head and neck using unsupervised machine-learning techniques. Materials and methods: We obtained IMRT/VMAT treatment planning data from 36 patients treated for head and neck cancers in a single institution. There were 1357 contours of more than 22 anatomical structures drawn on planning CTs. We calculated 174 radiomics features using the SIBEX program. First, we tested whether the radiomics features of anatomical structures were unique enough to classify all contours into 22 groups. We then developed a two-stage clustering technique to classify 22 anatomic structures into sub-groups with similar physiological or biological characteristics. Results: The heatmap of 174 radiomics features of 22 anatomical structures showed a distinct difference among tumors and other healthy structures. Radiomics features have allowed us to identify the eyes, lens, submandibular, pituitary glands, and thyroids with over 90% accuracy. The two-stage clustering of 22 structures resulted in six subgroups, which shared common characteristics such as fatty and bony tissues. Conclusions: We have shown that anatomical structures in head and neck tumors have distinguishable radiomics features. We could observe similarities of features among subgroups of the structures. The results suggest that CT radiomics can help distinguish the biological characteristics of head and neck lesions.

0 citations0 reviewsNo code linkedOpen access
preprint2016arXiv

Optimizing chemoradiotherapy to target multi-site metastatic disease and tumor growth

The majority of cancer-related fatalities are due to metastatic disease. In chemoradiotherapy, chemotherapeutic agents are administered along with radiation to increase damage to the primary tumor and control systemic disease such as metastasis. This work introduces a mathematical model to obtain optimal drug and radiation protocols in a chemoradiotherapy scheduling problem with the objective of minimizing metastatic cancer cell populations at multiple potential sites while maintaining a minimum level of damage to the primary tumor site. We derive closed-form expressions for an optimal chemotherapy fractionation regimen. A dynamic programming framework is used to determine the optimal radiotherapy fractionation regimen. Results show that chemotherapeutic agents do not change the optimal radiation fractionation regimens, and vice-versa. Interestingly, we observe that regardless of radio-sensitivity parameters, hypo-fractionated schedules are optimal solutions for the radiotherapy fractionation problem. Furthermore, it is optimal to immediately start radiotherapy. However, for chemotherapy, we find that the structure of the optimal schedule depends on model parameters such as chemotherapy-induced cell-kill at primary and metastatic sites, as well as the ability of primary tumor cells to initiate successful metastasis at different body sites. We quantify the trade-off between the new and traditional objectives of minimizing the metastatic population size and maximizing the tumor control probability, respectively, for a cervical cancer case. The trade-off information indicates the potential for significant reduction in the metastatic population with minimal loss in primary tumor control.

0 citations0 reviewsNo code linkedOpen access
preprint2015arXiv

A kinetic model of tumor growth and its radiation response with an application to Gamma Knife stereotactic radiosurgery

We developed a mathematical model to simulate the growth of tumor volume and its response to a single fraction of high dose irradiation. We made several key assumptions of the model. Tumor volume is composed of proliferating (or dividing) cancer cells and non-dividing (or dead) cells. Tumor growth rate (or tumor volume doubling time, Td) is proportional to the ratio of the volumes of tumor vasculature and the tumor. The vascular volume grows slower than the tumor by introducing the vascular growth retardation factor, theta. Upon irradiation the proliferating cells gradually die over a fixed time period after irradiation. Dead cells are cleared away with cell clearance time, Tcl. The model was applied to simulate pre-treatment growth and post-treatment radiation response of rat rhabdomyosarcoma tumor and metastatic brain tumors of five patients who were treated by Gamma Knife stereotactic radiosurgery (GKSRS). By selecting appropriate model parameters, we showed the temporal variation of the tumors for both the rat experiment and the clinical GKSRS cases could be easily replicated by the simple model. Additionally, the application of our model to the GKSRS cases showed that the alpha-value, which is an indicator of radiation sensitivity in the LQ model, and the retardation factor theta could be predictors of the post-treatment volume change. Since there is a large statistical uncertainty of this result due to the small sample size, a future clinical study with a larger number of patients is needed to confirm this finding.

0 citations0 reviewsNo code linkedOpen access
preprint2015arXiv

Robust and probabilistic optimization of dose schedules in radiotherapy

We consider the effects of parameter uncertainty on the optimal radiation schedule in the context of the linear-quadratic model. Our interest arises from the observation that if inter-patient variations in OAR and tumor sensitivities to radiation or sparing factor of the OAR are not accounted for during radiation scheduling, the performance of the therapy may be strongly degraded or the OAR may receive a substantially larger dose than the maximum threshold. This paper proposes two radiation scheduling concepts to incorporate inter-patient variability into the scheduling optimization problem. The first approach is a robust formulation that formulates the problem as a conservative model that optimizes the worst case dose scheduling that may occur. The second method is a probabilistic approach, where the model parameters are given by a set of random variables. This formulation insures that our constraints are satisfied with a given probability, and that our objective function achieves a desired level with a stated probability. We used a transformation to reduce the resulting optimization problem to two dimensions. We showed that the optimal solution lies on the boundary of the feasible region and we used a branch and bound algorithm to find the global optimal solution. We observed that if the number of fractions in the optimal conventional schedule is the same as the robust and stochastic solutions, it is preferable to administer equal or smaller total dose. In addition if there exist more (fewer) treatment sessions in the probabilistic or robust solution compared to the conventional schedule, a reduction in total dose squared (total dose) will be expected. Finally, we performed numerical experiments in the setting of head-and-neck tumors to reveal the effect of parameter uncertainty on optimal schedules and to evaluate the sensitivity of the model to the choice of key model parameters.

0 citations0 reviewsNo code linkedOpen access